The Synergistic Effect of Conditional Pten Loss and Oncogenic K-ras Mutation on Endometrial Cancer Development Occurs via Decreased Progesterone Receptor Action.
about
Dysregulation of uterine signaling pathways in progesterone receptor-Cre knockout of dicer.Genetics of endometrial cancersCooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis.Physiological and molecular determinants of embryo implantationMig-6 plays a critical role in the regulation of cholesterol homeostasis and bile acid synthesis.A novel functional interplay between Progesterone Receptor-B and PTEN, via AKT, modulates autophagy in breast cancer cells.Prevention of K-Ras- and Pten-mediated intravaginal tumors by treatment with camptothecin-loaded PLGA nanoparticles.Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis.Influence of AKT on progesterone action in endometrial diseases.The genomics and genetics of endometrial cancer.Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapyAnother surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy.Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivo.MicroRNAs and their role in gynecological tumors.KRAS Activation and over-expression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone Resistance.Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.Progression inference for somatic mutations in cancer.Oncogenic HrasG12V expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma.Dual expression of immunoreactive estrogen receptor β and p53 is a potential predictor of regional lymph node metastasis and postoperative recurrence in endometrial endometrioid carcinoma.
P2860
Q30417482-FF4AA125-0CB1-4765-B635-F3F472094CBFQ33781274-9830BCC0-19EB-469B-BEBD-873572E3F49BQ34300546-AA8CDBF8-F4DB-44A3-BAA9-AE104F8CD9ACQ34320970-AA0E9B71-9643-44D2-92B7-9E378ED7EC1CQ34389069-7EA2DBE6-3C39-46D0-A776-1CB8AFC3000AQ34473669-C2980E7D-2FF4-4843-BC7C-D7E055E3115CQ34550788-CB01DC87-6555-46F6-9F2D-A1571686D97EQ35132940-C34481D8-1EB0-4FDB-B747-57E6A48A1780Q35617565-13965835-2C6C-475F-ACE9-26E655E64B60Q36151896-9780EBE4-03B8-44BD-970A-86A7071EA3BDQ37118392-46872209-AE74-471A-A65C-3CC21E5A360EQ37444285-AE1505D4-61AF-4266-A14F-B0DDDED47792Q37524037-D6FC89B2-2CDE-4452-AA22-EAA3294A796EQ37722649-9FB58F5E-1B06-4408-B107-56893254C532Q38654299-CD7DB2BC-0C69-418A-BE36-707633ABBB12Q38788210-18CA143E-E5C4-411D-AA5A-BE4E92700095Q38793244-75F29405-3E0C-44E1-9542-E757BD32A781Q41923500-6DD30931-9DA4-4145-ADCD-58BBE5B0341DQ47148114-E8AF7ABC-A481-48DB-AE7D-C65F4CF28CD5
P2860
The Synergistic Effect of Conditional Pten Loss and Oncogenic K-ras Mutation on Endometrial Cancer Development Occurs via Decreased Progesterone Receptor Action.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The Synergistic Effect of Cond ...... Progesterone Receptor Action.
@en
The Synergistic Effect of Cond ...... Progesterone Receptor Action.
@nl
type
label
The Synergistic Effect of Cond ...... Progesterone Receptor Action.
@en
The Synergistic Effect of Cond ...... Progesterone Receptor Action.
@nl
prefLabel
The Synergistic Effect of Cond ...... Progesterone Receptor Action.
@en
The Synergistic Effect of Cond ...... Progesterone Receptor Action.
@nl
P2093
P2860
P356
P1433
P1476
The Synergistic Effect of Cond ...... Progesterone Receptor Action.
@en
P2093
Francesco J Demayo
Heather L Franco
Jae-Wook Jeong
Jinrong Wang
John P Lydon
Kevin Y Lee
Russell R Broaddus
Tae Hoon Kim
P2860
P304
P356
10.1155/2010/139087
P577
2009-10-27T00:00:00Z